Healthcare -
Biotechnology - NASDAQ - US
$ 1.39
-2.11 %
$ 161 M
Market Cap
-15.44
P/E
CHRS - CAPITAL EXPENDITURES
Capital Expenditures CHRS - Coherus BioSciences, Inc.
-286 K
LAST VALUE
52.90%
2 YEAR CAGR
18.37%
5 YEAR CAGR
2.62%
10 YEAR CAGR